The following publication discusses the latest research regarding the Non-Invasive Biomarkers of Nonalcoholic Steatohepatitis (NASH). Nature Medicine originally published this article, coauthored by ERG’s Vice President of Clinical Pharmacology Services Clay Dehn, on February 10th, 2022.
If you or someone you know is affected by depression, upcoming clinical trials may be an option. Learn more today!
Schizophrenia can affect anyone. If you or someone you know is living with schizophrenia, you may qualify for a clinical trial.
If you or someone you know is diagnosed with diabetes, you may qualify for a clinical trial. Learn more about today.
